Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The role of tumor-infiltrating immune cells in the early metastatic invasion of colorectal cancer is unknown. METHODS: We studied pathological signs of early metastatic invasion (venous emboli and lymphatic and perineural invasion) in 959 specimens of resected colorectal cancer. The local immune response within the tumor was studied by flow cytometry (39 tumors), low-density-array real-time polymerase-chain-reaction assay (75 tumors), and tissue microarrays (415 tumors). RESULTS: Univariate analysis showed significant differences in disease-free and overall survival according to the presence or absence of histologic signs of early metastatic invasion (P<0.001). Multivariate Cox analysis showed that an early conventional pathological tumor-node-metastasis stage (P<0.001) and the absence of early metastatic invasion (P=0.04) were independently associated with increased survival. As compared with tumors with signs of early metastatic invasion, tumors without such signs had increased infiltrates of immune cells and increased levels of messenger RNA (mRNA) for products of type 1 helper effector T cells (CD8, T-BET [T-box transcription factor 21], interferon regulatory factor 1, interferon-gamma, granulysin, and granzyme B) but not increased levels of inflammatory mediators or immunosuppressive molecules. The two types of tumors had significant differences in the levels of expression of 65 combinations of T-cell markers, and hierarchical clustering showed that markers of T-cell migration, activation, and differentiation were increased in tumors without signs of early metastatic invasion. The latter type of tumors also had increased numbers of CD8+ T cells, ranging from early memory (CD45RO+CCR7-CD28+CD27+) to effector memory (CD45RO+CCR7-CD28-CD27-) T cells. The presence of high levels of infiltrating memory CD45RO+ cells, evaluated immunohistochemically, correlated with the absence of signs of early metastatic invasion, a less advanced pathological stage, and increased survival. CONCLUSIONS: Signs of an immune response within colorectal cancers are associated with the absence of pathological evidence of early metastatic invasion and with prolonged survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Examination of the lymphocytes that correlated with such beneficial outcomes has repeatedly implicated effector and memory CD8 + T cell and NK cell populations (136-141).”
From Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance (2021) · cites this paper as [136]
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,330
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
TNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,946
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
Research works printed but not linked: 2
- 10.1002/(sici)1097-0142(20000401)88:7<1739::aid-cncr30>3.0.co;2-t · DOI · Paper page
- 10.1002/(sici)1097-0215(19990621)84:3<326::aid-ijc22>3.0.co;2-k · DOI · Paper page
Cited by
Items 301–400 of 1,001
Yaqub, S., Henjum, K., Mahic, M., Jahnsen, F. L., Aandahl, E. M., Bjørnbeth, B. A., & Taskén, K. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0417-x · Cited by 148
“Tumor cells are immunogenic and tumor-inWltrating lymphocytes (TILs) in melanoma, CRC, and ovarian cancer inhibit tumor growth and are associated with improved prognosis [9, 32 , 49].”
BackgroundDarrasse-Jèze, G., Bergot, A.-S., Durgeau, A., Billiard, F., Salomon, B. L., Cohen, J. L., Bellier, B., Podsypanina, K., & Klatzmann, D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36628 · Cited by 138
“Also noteworthy is the previous finding that detection of memory Teffs correlated with good prognosis in cancer patients (70, 71).”
BackgroundThe Immune Microenvironment of Human Tumors: General Significance and Clinical Impact
Fridman, W. H., Dieu‐Nosjean, M., Pagès, F., Cremer, I., Damotte, D., Sautès‐Fridman, C., & Galon, J. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0124-9 · Cited by 178
“a 30 years ago [60], its functional orientation 15 years ago [61, 62] has been deeply explored during the last decade [16, 32, 63] and resulted in the demonstration that immune quantification is more powerful than traditional staging to predict outcome [16, 18].”
Self-citationYao, W., He, J., Yang, Y., Wang, J., Qian, Y., Yang, T., & Ji, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-08128-1 · Cited by 152
Katz, S. C., Pillarisetty, V. G., Bamboat, Z. M., Shia, J., Hedvat, C. V., Gönen, M., Jarnagin, W. R., Fong, Y., Blumgart, L. H., D'Angelica, M. I., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0585-3 · Cited by 153
Pine, J. K., Morris, E. J. A., Hutchins, G. G. A., West, N. P., Jayne, D. G., Quirke, P., & Prasad, R. K. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.87 · Cited by 143
“The presence of tumourinfiltrating lymphocytes in CRC has also been shown to confer a better prognosis (Pages et al, 2005; Galon et al, 2006).”
BackgroundUjiie, H., Kadota, K., Nitadori, J.-I., Aerts, J. G., Woo, K. M., Sima, C. S., Travis, W. D., Jones, D. R., Krug, L. M., & Adusumilli, P. S. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1009285 · Cited by 135
TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
Sauer, N. J., Janicka, N., Szlasa, W., Skinderowicz, B., Kołodzińska, K., Dwernicka, W., Oślizło, M., Kulbacka, J., Novickij, V., & Karłowicz-Bodalska, K. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03516-1 · Cited by 158
“As CD8 + T cells migrate to tumor sites to eliminate tumor cells [87], an increase in the number of tumor-infiltrating CD8 + T cells in the tumor microenvironment correlates with better clinical outcomes in human cancers [88–91].”
BackgroundPredicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells
Quigley, D. A., & Kristensen, V. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.003 · Cited by 133
Lin, Y.-H., Friederichs, J., Black, M. A., Mages, J., Rosenberg, R., Guilford, P. J., Phillips, V., Thompson-Fawcett, M., Kasabov, N., Toro, T., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2734 · Cited by 132
The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
Itatani, Y., Kawada, K., Inamoto, S., Yamamoto, T., Ogawa, R., Taketo, M., & Sakai, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050643 · Cited by 132
Ribas, A., Comin-Anduix, B., Economou, J. S., Donahue, T. R., de la Rocha, P., Morris, L. F., Jalil, J., Dissette, V. B., Shintaku, I. P., Glaspy, J. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0783 · Cited by 132
Colorectal cancer and immunity: What we know and perspectives
Pernot, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3738 · Cited by 131
Tumor Infiltrating T Lymphocytes in Colorectal Cancer
Koch, M., Beckhove, P., den Winkel, J. O., Autenrieth, D., Wagner, P., Nummer, D., Specht, S., Antolovic, D., Galindo, L., Schmitz-Winnenthal, F. H., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000247058.43243.7b · Cited by 131
“Pagès et al could demonstrate that T cell responses within colorectal cancer are significantly associated with the absence of early metastatic invasion (eg, vascular emboli, lymphatic invasion, and perineural invasion) in the tumor and result in a significantly prolonged survival of the patients.(9) However, a clear c…”
BackgroundBerghoff, A. S., Ricken, G., Wilhelm, D., Rajky, O., Widhalm, G., Dieckmann, K. U., Birner, P., Bartsch, R., & Preusser, M. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2216-8 · Cited by 137
Lugli, A., Karamitopoulou, E., Panayiotides, I., Karakitsos, P., Rallis, G., Peros, G., Iezzi, G., Spagnoli, G., Bihl, M., Terracciano, L., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605318 · Cited by 128
“…studies have shown that tumour infiltrating lymphocytes (TILs) within the stroma and around the tumour along the invasive margin are significantly related to overall- and diseasespecific survival in both univariate and multivariable analysis (Ali et al, 2004; Canna et al, 2005; Pages et al, 2005).”
BackgroundTargeting DDR2 enhances tumor response to anti–PD-1 immunotherapy
Tu, M. M., Lee, F. Y., Jones, R. T., Kimball, A. K., Saravia, E., Graziano, R. F., Coleman, B. M., Menard, K., Yan, J., Michaud, E., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav2437 · Cited by 141
Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion
Montes, C. L., Chapoval, A. I., Nelson, J., Orhue, V., Zhang, X., Schulze, D. H., Strome, S. E., & Gastman, B. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2282 · Cited by 127
“poor prognostic indicator in the tumor microenvironment, the opposite has been shown (33, 34).”
BackgroundYang, I., Han, S. J., Sughrue, M. E., Tihan, T., & Parsa, A. T. (2011) · Journal of Neurosurgery · doi:10.3171/2011.4.jns101172 · Cited by 127
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
Loddenkemper, C., Schernus, M., Noutsias, M., Stein, H., Thiel, E., & Nagorsen, D. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-52 · Cited by 129
“[47] measured FOXP3 at the RNA level in CRC and found no difference in survival comparing high and low expression.”
Efficient Treg depletion induces T‐cell infiltration and rejection of large tumors
Li, X., Kostareli, E., Suffner, J., Garbi, N., & Hämmerling, G. J. (2010) · European Journal of Immunology · doi:10.1002/eji.201041093 · Cited by 126
Characteristics and significance of colorectal cancer associated lymphoid reaction
Väyrynen, J. P., Väyrynen, S. A., Klintrup, K., Mäkelä, J. T., Herzig, K., Karttunen, T. J., Tuomisto, A., & Mäkinen, M. J. (2013) · International Journal of Cancer · doi:10.1002/ijc.28533 · Cited by 133
HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker
Sconocchia, G., Eppenberger-Castori, S., Zlobec, I., Karamitopoulou, E., Arriga, R., Coppola, A., Caratelli, S., Cesare Spagnoli, G., Lauro, D., Lugli, A., et al. (2014) · Neoplasia · doi:10.1593/neo.131568 · Cited by 124
“The expression of HLA class II antigens could be a result of the activation of an inflammatory response mediated by immune cells infiltrating the tumor microenvironment [2,20,30–36].”
BackgroundMalesci, A., Bianchi, P., Celesti, G., Basso, G., Marchesi, F., Grizzi, F., Di Caro, G., Cavalleri, T., Rimassa, L., Palmqvist, R., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1342918 · Cited by 124
Immunosurveillance in clinical cancer management
Kroemer, G., Chan, T. A., Eggermont, A. M. M., & Galluzzi, L. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21818 · Cited by 123
“24 This led to the development of a standardized test measuring the density of CD3 ‐ positive and CD8 ‐ positive T lymphocytes within the tumor and at its invasive margin using immunohistochemistry on formaldehyde ‐ fixed, paraffin ‐ embedded tissue sections and digital pathology, referred to as…”
BackgroundZabijak, L., Attencourt, C., Guignant, C., Chatelain, D., Marcelo, P., Marolleau, J., & Treiner, E. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1764-7 · Cited by 138
“An effective antitumoral response requires a Th1-like differentiation of T cells and an infiltration by both CD4+ and cytolytic CD8+ T cells [3], however, TIL often include ineffective Th2 T cells, as well as regulatory T cells (Tregs), which may prevent the action of anti-tumoral T cells [4–9].”
BackgroundThe role of mast cells in cancers
Maciel, T. T., Moura, I. C., & Hermine, O. (2015) · F1000Prime Reports · doi:10.12703/p7-09 · Cited by 123
“In this setting, the extent of type 1 helper (Th1) effector CD8+ cells has been shown to be a marker of clinical response suggesting that, in particular conditions, immune cells can exert anti-tumor effects [2,3].”
BackgroundMao, Y., Li, W., Chen, K., Xie, Y., Liu, Q., Yao, M., Duan, W., Zhou, X., Liang, R., & Tao, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3097 · Cited by 123
“Scores from 0 to 1 were considered low infiltration, whereas scores from 2 to 3 were defined as high infiltration.[34]”
BackgroundMorris, M., Platell, C., & Iacopetta, B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1994 · Cited by 123
Guo, L., Wang, C., Qiu, X., Pu, X., & Chang, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01052 · Cited by 122
“(16) CRC I–IV 75 PCR for mRNA encoding CD8, T-bet,”
BackgroundWu, X., Zhang, H.-B., Xing, Q. R., Cui, J., Li, J., Li, Y., Tan, Y. Q., & Wang, S. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.416 · Cited by 134
“Human CRCs with a high density of infiltrating memory and effector memory (CD45ROþ ) T cells were less likely to disseminate to lymphovascular and perineural structures and to regional lymph nodes (Pages et al, 2005).”
BackgroundLynch, K., Young, S. J., Meneveau, M. O., Wages, N. A., Engelhard, V. H., Slingluff, C. L., & Mauldin, I. S. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002273 · Cited by 174
Invasive front of colorectal cancer: Dynamic interface ofpro-/anti-tumor factors
Zlobec, I., & Lugli, A. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5898 · Cited by 139
Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
Pancione, M., Giordano, G., Remo, A., Febbraro, A., Sabatino, L., Manfrin, E., Ceccarelli, M., & Colantuoni, V. (2014) · Journal of Immunology Research · doi:10.1155/2014/686879 · Cited by 142
Clinical impact of tumor‐infiltrating lymphocytes for survival in stage II colon cancer
Lee, W., Park, S., Lee, W. Y., Yun, S. H., & Chun, H. (2010) · Cancer · doi:10.1002/cncr.25293 · Cited by 121
“T cells that were positive for the protein tyrosine phosphatase CD45 isoform RO (CD45RO) also reportedly had prognostic significance.(14,15) Oberg et al(14) reported that a high density of CD45RO-positive T cells in lymph node metastases from colon cancer was associated with an improved prognosis, and Pages et al(15)…”
BackgroundPrognostic value of tumour necrosis and host inflammatory responses in colorectal cancer
Richards, C. H., Roxburgh, C. S. D., Anderson, J. H., McKee, R. F., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2012) · Journal of British Surgery · doi:10.1002/bjs.7755 · Cited by 121
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma
Song, L., Ara, T., Wu, H., Woo, C., Reynolds, C. P., Seeger, R. C., DeClerck, Y. A., Thiele, C. J., Sposto, R., & Metelitsa, L. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30751 · Cited by 131
“A recent large study of 415 samples from patients with colon cancer demonstrated that patients whose tumors had a high density of tumor-infiltrating CD45Ro+ effector-memory T cells had a more than 3-fold higher rate of disease-free and overall long-term survival compared with those patients with tumors containing a lo…”
The diverse roles of the TNF axis in cancer progression and metastasis.
Ham, B., Fernández, M. C., D'Costa, Z., & Brodt, P. (2016) · PubMed · Cited by 149
CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
Gu, Y., Li, X., Bi, Y., Zheng, Y., Wang, J., Li, X., Huang, Z., Chen, L., Huang, Y., & Huang, Y. (2020) · Aging · doi:10.18632/aging.102656 · Cited by 133
Colitis-associated cancer: the role of T cells in tumor development
Waldner, M. J., & Neurath, M. F. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0161-8 · Cited by 139
“Indeed, a Th2 response has also been correlated with the progression of experimental and human sporadic CRC [40, 41], whereas a Th1 response has been associated with an improved prognosis in this disease [42].”
Hypoxia and the phenomenon of immune exclusion
Pietrobon, V., & Marincola, F. M. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02667-4 · Cited by 119
Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
Disis, M. L. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0960-8 · Cited by 120
“compared with patient tumor samples that had a low density of infiltrating memory T cells, n = 336 samples [23].”
ResultThe Future of Immune Checkpoint Cancer Therapy After PD-1 and CTLA-4
Hahn, A. W., Gill, D. M., Pal, S. K., & Agarwal, N. (2017) · Immunotherapy · doi:10.2217/imt-2017-0024 · Cited by 117
Predictive biomarkers for response to immune checkpoint inhibition
Shum, B., Larkin, J., & Turajlic, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.036 · Cited by 134
The essential role of the in situ immune reaction in human colorectal cancer
Pagès, F., Galon, J., & Fridman, W. H. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107773 · Cited by 130
“Immunostaining was quantified using a dedicated image analysis workstation, providing a robust and reliable method [17] to determine the density of immunostained cells.”
BackgroundMethodInfluentialSelf-citationYang, W., Li, Y., Gao, R., Xiu, Z., & Sun, T. (2019) · Oncogene · doi:10.1038/s41388-019-1045-6 · Cited by 121
Liu, J. Y., Li, F., Wang, L. P., Chen, X. F., Wang, D., Cao, L., Ping, Y., Zhao, S., Li, B., Thorne, S. H., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.290 · Cited by 116
“Infiltration of CD8þ T lymphocytes usually favours better prognosis and prolonged survival, whereas tumoural presence of regulatory T (Treg) lymphocytes means poor prognosis (Zhang et al, 2003; Curiel et al, 2004; Pages et al, 2005; Sato et al, 2005; Galon et al, 2006).”
BackgroundWang, X., Zhao, X., Feng, C., Weinstein, A., Xia, R., Wen, W., Lv, Q., Zuo, S., Tang, P., Yang, X., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.014 · Cited by 116
“Many tumors induce adaptive immune responses, and the higher number of tumor-infiltrating type 1 lymphocytes, defined as interferon g (IFN-g)-producing lymphocytes, correlates with a better prognosis for cancer patients (Chen et al., 2013; Galon et al., 2006; Lu et al., 2011; Pagès et al., 2005; Willimsky et al., 2008…”
Circulating and Tumor-Infiltrating Myeloid Cells Predict Survival in Human Pleural Mesothelioma
Burt, B. M., Rodig, S. J., Tilleman, T. R., Elbardissi, A. W., Bueno, R., & Sugarbaker, D. J. (2011) · Cancer · doi:10.1002/cncr.26143 · Cited by 115
“In fact, these indices are more sensitive than current histological methods for the estimation of survival in patients with colorectal cancer.(27,28) It has been known for some time that MPM tumors contain an abundance of intratumoral leukocytes,(29) but it is only recently that the composition and phenotype of these…”
BackgroundDroeser, R. A., Hirt, C., Eppenberger-Castori, S., Zlobec, I., Viehl, C. T., Frey, D. M., Nebiker, C. A., Rosso, R., Zuber, M., Amicarella, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064814 · Cited by 115
“Infiltration by activated CD8+ memory T cells and expression of IFN-c gene within CRC were convincingly shown to be associated with favorable prognosis [5,7].”
BackgroundMeshcheryakova, A., Tamandl, D., Bajna, E., Stift, J., Mittlboeck, M., Svoboda, M., Heiden, D., Stremitzer, S., Jensen‐Jarolim, E., Gruenberger, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099008 · Cited by 128
Tumor microenvironment is multifaceted
Sautès‐Fridman, C., Cherfils‐Vicini, J., Damotte, D., Fisson, S., Fridman, W. H., Cremer, I., & Dieu‐Nosjean, M. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9279-y · Cited by 129
“Nevertheless, it is striking that a high degree of variability of the extent and composition of the immune infiltrates exist among individuals, even for a given cancer [13, 14 ].”
BackgroundSelf-citationHamada, T., Keum, N., Nishihara, R., & Ogino, S. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-016-1272-3 · Cited by 114
Pang, Q., An, R., & Liu, H. (2019) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1551-y · Cited by 122
“metastasis [40, 41], and transfusion could accelerate tumour progression by inducing an inflammatory response and immunosuppression [42].”
BackgroundKarlsson, A., Jönsson, M., Lauss, M., Brunnström, H., Jönsson, P., Borg, Å., Jönsson, G. B., Ringnér, M., Planck, M., & Staaf, J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1087 · Cited by 120
“While the generally better prognosis of ES5 cases may be attributable to their lower proliferation rate, the better prognosis of ES2 patients compared to ES1 could, hypothetically, be related to an altered and/or reduced immune cell infiltration in ES1, which have been shown to confer a poorer prognosis in multiple ca…”
BackgroundProduction of Adenosine by Ectonucleotidases: A Key Factor in Tumor Immunoescape
Ghiringhelli, F., Bruchard, M., Chalmin, F., & Rébé, C. (2012) · BioMed Research International · doi:10.1155/2012/473712 · Cited by 133
“In humans, recent data demonstrate that infiltration of the tumor bed by CD8 and memory T cells correlates with good outcomes, while tumor-bed infiltration by immunosuppressive cells correlates with poor outcomes [3–5].”
BackgroundSissy, C. E., Kirilovsky, A., den Eynde, M. V., Mușină, A.-M., Aniței, M.-G., Romero, A., Marliot, F., Junca, A., Doyen, J., Mlecnik, B., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0337 · Cited by 126
“Natural immune reaction at tumor site has been further associated with a favorable prognosis in various cancers (13), including colorectal cancer, treated by surgery alone (14, 15).”
BackgroundSelf-citationSullivan, R., Maresh, G., Zhang, X., Salomon, C., Hooper, J., Margolin, D., & Li, L. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00194 · Cited by 112
“This concept has also been demonstrated in many other malignancies including colorectal cancer, where an active TME and signs of an immune response were associated with the absence of early metastasis and increased survival (12).”
BackgroundSconocchia, G., Zlobec, I., Lugli, A., Calabrese, D., Iezzi, G., Karamitopoulou, E., Patsouris, E. S., Peros, G., Horcic, M., Tornillo, L., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25609 · Cited by 112
“Discussion There is substantial evidence that adaptive immune response is able to counteract CRC progression.(3,5) However, the role played by the innate immune system in this process is still controversial.”
BackgroundWei, C., Liang, Q., Li, X., Li, H., Liu, Y., Huang, X., Chen, X., Guo, Y., & Li, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28754 · Cited by 113
“Immune cells, known as tumor killers, are able to perturb the molecular signal and play crucial roles in cancer biology, including those closely related to tumor proliferation, metastasis, and invasion.(3,4) Nevertheless, some cancer cells are able to avoid detection by the immune system; to repress immune responses,…”
BackgroundThibaudin, M., Fumet, J.-D., Chibaudel, B., Bennouna, J., Borg, C., Martin-Babau, J., Cohen, R., Fonck, M., Taïeb, J., Limagne, E., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02497-z · Cited by 126
“Many studies have underlined that the immune system recognizes CRC, and high CD8 T cell infiltrates are associated with better prognosis in localized or metastatic CRC 13,14 .”
Ling, A., Edin, S., Wikberg, M. L., Öberg, Å., & Palmqvist, R. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.161 · Cited by 111
“Earlier work by Pages et al (2005) has shown a correlation between high tumour immune cell infiltration and absence of perineural invasion and lymphatic emboli.”
MethodTumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer
Liu, K., Yang, K., Wu, B., Chen, H., Chen, X., Chen, X., Jiang, L., Ye, F., He, D., Lu, Z., et al. (2015) · Medicine · doi:10.1097/md.0000000000001631 · Cited by 111
Roufas, C., Chasiotis, D., Makris, A., Efstathiades, C., Dimopoulos, C., & Zaravinos, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00027 · Cited by 125
Activated innate lymphoid cell populations accumulate in human tumour tissues
Salimi, M., Wang, R., Yao, X., Li, X., Wang, X., Hu, Y., Chang, X., Fan, P., Dong, T., & Ogg, G. S. (2018) · BMC Cancer · doi:10.1186/s12885-018-4262-4 · Cited by 121
“In colorectal cancer, infiltration of effector memory CD8+ T cells is associated with a reduction in early invasion and improved survival [4].”
Mast cells: A double-edged sword in cancer
Derakhshani, A., Vahidian, F., Alihasanzadeh, M., Mokhtarzadeh, A., Lotfi Nezhad, P., & Baradaran, B. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.03.011 · Cited by 111
Loupakis, F., Depetris, I., Biason, P., Intini, R., Prete, A. A., Leone, F., Lombardi, P., Filippi, R., Spallanzani, A., Cascinu, S., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2019-0611 · Cited by 111
“Recently, accumulating evidence demonstrated an association between high number of TILs and prognosis in colorectal cancer (CRC) [15–17], suggesting that host immune response to tumor cells is essential to determine outcomes of patients with CRC [18].”
BackgroundMelaiu, O., Mina, M., Chierici, M., Boldrini, R., Jurman, G., Romania, P., D’Alicandro, V., Benedetti, M. C., Castellano, A., Liu, T., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2601 · Cited by 122
“In general, high density of effector and memory T cells has been correlated with good clinical outcome (2, 3), whereas the prevalence of myeloid cells is associated with poor prognosis (4).”
BackgroundColon cancer cells produce immunoregulatory glucocorticoids
Sidler, D., Renzulli, P., Schnoz, C., Berger, B., Schneider-Jakob, S., Flück, C., Inderbitzin, D., Corazza, N., Candinas, D., & Brunner, T. (2011) · Oncogene · doi:10.1038/onc.2010.629 · Cited by 107
“In line with this notion are recent findings demonstrating that the degree of tumor infiltration by memory CD8þ T cells strongly correlates with the overall survival of CRC patients (Pages et al., 2005; Galon et al., 2006), indicating that anti-tumor immune responses are able to significantly limit tumor growth.”
The colorectal cancer immune microenvironment and approach to immunotherapies
Koi, M., & Carethers, J. M. (2017) · Future Oncology · doi:10.2217/fon-2017-0145 · Cited by 131
The use of digital pathology and image analysis in clinical trials
Pell, R., Oien, K., Robinson, M., Pitman, H., Rajpoot, N., Rittscher, J., Snead, D., Verrill, C., & on behalf of the UK National Cancer Research Institute (NCRI) Cellular‐Molecular Pathology (CM‐Path) quality assurance working group (2019) · The Journal of Pathology: Clinical Research · doi:10.1002/cjp2.127 · Cited by 109
“…is the underlying basis for the Immunoscore ™ (Laboratory of Integrative Cancer Immunology INSERM, Paris, France) technique in colorectal adenocarcinoma: patients with a low CD3+ and CD8+ T cell density in the tumour centre and invasive margin are at an increased risk for disease relapse [45,46].”
The prognostic impact of anti-cancer immune response: a novel classification of cancer patients
Bindea, G., Mlecnik, B., Fridman, W. H., & Galon, J. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0264-x · Cited by 121
“They were confirmed recently by studies underlining the prominent role of memory T cells [14] and CD8+ T cells [45] in predicting disease-free and overall survival.”
BackgroundResultSelf-citationBossard, C., Bezieau, S., Matysiak‐Budnik, T., Volteau, C., LABOISSE, C. L., Jotereau, F., & Mosnier, J. (2011) · International Journal of Cancer · doi:10.1002/ijc.26453 · Cited by 116
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.
Uppaluri, R., Dunn, G. P., & Lewis, J. S. (2008) · PubMed · Cited by 112
End-to-end prognostication in colorectal cancer by deep learning: a retrospective, multicentre study
Jiang, X., Hoffmeister, M., Brenner, H., Muti, H. S., Yuan, T., Foersch, S., West, N. P., Brobeil, A., Jonnagaddala, J., Hawkins, N., et al. (2024) · The Lancet Digital Health · doi:10.1016/s2589-7500(23)00208-x · Cited by 108
Oudard, S., Rixe, O., Beuselinck, B., Linassier, C., Banu, E., Machiels, J., Baudard, M., Ringeisen, F., Velu, T., Lefrère-Belda, M., et al. (2011) · Cancer Immunology and Immunotherapy · doi:10.1007/s00262-010-0935-9 · Cited by 101
Self-citationPaschall, A. V., Yang, D., Lu, C., Choi, J.-H., Li, X., Liu, F., Figueroa, M., Oberlies, N. H., Pearce, C., Bollag, W. B., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402243 · Cited by 107
“that presence of tumor-specific CTLs in the tumor microenvironment is positively correlated with the absence of early metastasis and increased survival of CRC patients (17, 57, 58).”
BackgroundExpanding Roles for CD4 T Cells and Their Subpopulations in Tumor Immunity and Therapy
Dobrzanski, M. J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00063 · Cited by 124
“This has been shown in studies with cancer patients where increased intratumoral memory T cell levels were associated with longer disease free and overall survival rates (Pagès et al., 2005; Bindea et al., 2010).”
ResultTurcotte, S., Gros, A., Hogan, K., Tran, E., Hinrichs, C. S., Wunderlich, J. R., Dudley, M. E., & Rosenberg, S. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300538 · Cited by 107
“with aggressive features such as microvascular and perineural invasion compared with tumor with more favorable pathological features (16).”
BackgroundIntestinal inflammation and colorectal cancer: a double-edged sword?
Rizzo, A., Pallone, F., Monteleone, G., & Fantini, M. C. (2011) · PubMed · doi:10.3748/wjg.v17.i26.3092 · Cited by 107
Spatial and phenotypic immune profiling of metastatic colon cancer
Lazarus, J., Maj, T., Smith, J. J., Perusina Lanfranca, M., Rao, A., D’Angelica, M. I., Delrosario, L., Girgis, A., Schukow, C., Shia, J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121932 · Cited by 107
Perineural invasion in colorectal cancer: mechanisms of action and clinical relevance
Wang, H., Huo, R., He, K., Li, C., Zhang, S., Yu, M., Zhao, W., Li, H., & Xue, J. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00857-y · Cited by 120
Ménard, C., Ghiringhelli, F., Roux, S., Chaput, N., Mateus, C., Grohmann, U., Caillat-Zucman, S., Zitvogel, L., & Robert, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4797 · Cited by 106
Immune Activation in Mismatch Repair–Deficient Carcinogenesis: More Than Just Mutational Rate
Willis, J. A., Reyes-Uribe, L., Chang, K., Lipkin, S. M., & Vilar, E. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0856 · Cited by 117
“Similarly, the presence of CD45RO, CD8þ, and CD4þ cells is associated with lower rates of metastasis, vascular, or perineural invasion, respectively (85).”
BackgroundTertiary Intratumor Lymphoid Tissue in Colo-Rectal Cancer
Bergomas, F., Grizzi, F., Doni, A., Pesce, S., Laghi, L., Allavena, P., Mantovani, A., & Marchesi, F. (2011) · Cancers · doi:10.3390/cancers4010001 · Cited by 109
“prognosis in different tumor types, (including melanoma) [16] as well as ovarian [17] and colon cancer [18,19], suggesting that an antitumor T-cell immune response may take place in vivo in patients with solid tumors.”
BackgroundNerve Fibers in Breast Cancer Tissues Indicate Aggressive Tumor Progression
Huang, D., Su, S., Cui, X., Shen, X., Zeng, Y., Wu, W., Chen, J., Chen, F., He, C., Liu, J., et al. (2014) · Medicine · doi:10.1097/md.0000000000000172 · Cited by 105
Yap suppresses T-cell function and infiltration in the tumor microenvironment
Stampouloglou, E., Cheng, N., Federico, A., Slaby, E., Monti, S., Szeto, G. L., & Varelas, X. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000591 · Cited by 104
Fanfone, D., Wu, Z., Mammi, J., Berthenet, K., Neves, D., Weber, K., Halaburkova, A., Virard, F., Bunel, F., Jamard, C., et al. (2022) · eLife · doi:10.7554/elife.73150 · Cited by 115
Tumor-Induced CD8+ T-Cell Dysfunction in Lung Cancer Patients
Prado-García, H., Romero‐Garcia, S., Aguilar‐Cázares, D., Meneses-Flores, M., & López-González, J. S. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/741741 · Cited by 133
“In tumors such as colorectal cancer [60, 61] and ovarian carcinoma [62], high densities of intratumoral memory (CD45RO+) cells and CD8+ T-cells are localized and correlate with favorable prognosis.”
BackgroundT-cell death and cancer immune tolerance
Lu, B., & Finn, O. J. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402274 · Cited by 119
“For example, the presence of intratumoral T cells correlates with better clinical outcome in advanced colorectal carcinoma.(12) A higher density of memory T-cell markers within a tumor is favorably associated with overall survival of colorectal cancer patients.”
BackgroundFotin‐Mleczek, M., Zanzinger, K., Heidenreich, R., Lorenz, C., Thess, A., Duchardt, K. M., & Kallen, K. (2012) · The Journal of Gene Medicine · doi:10.1002/jgm.2605 · Cited by 103
Park, J. S., Rhau, B., Hermann, A., McNally, K. A., Zhou, C., Gong, D., Weiner, O. D., Conklin, B. R., Onuffer, J., & Lim, W. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402087111 · Cited by 103
Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
Mulet-Margalef, N., Linares, J., Badia-Ramentol, J., Jimeno, M., Sanz, C., Mozo, J. L. M., & Calon, A. (2023) · Cancers · doi:10.3390/cancers15041022 · Cited by 124
Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance
Hopewell, E. L., Zhao, W., Fulp, W. J., Bronk, C. C., Lopez, A. S., Massengill, M., Antonia, S., Celis, E., Haura, E. B., Enkemann, S. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67250 · Cited by 103
“The presence of tumor-infiltrating T cells, which likely recognize tumor-expressed antigens, is associated with improved patient survival (13–15).”
Cancer Immunoediting in Malignant Glioma
Dunn, G. P., Fecci, P. E., & Curry, W. T. (2012) · Neurosurgery · doi:10.1227/neu.0b013e31824f840d · Cited by 104
Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer
Marchesi, F., Locatelli, M., Solinas, G., Erreni, M., Allavena, P., & Mantovani, A. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.007 · Cited by 114
“Although recent analyses in different tumor types have quoted perineural invasion as an independent prognostic factor (Harnden et al., 2007; Liebig et al., 2009; Liu and Lu, 2002; Pages et al., 2005), this parameter is not always taken into consideration and its clinical significance remains underestimated.”
BackgroundImmune scores in colorectal cancer: Where are we?
Malka, D., Lièvre, A., André, T., Taïeb, J., Ducreux, M. P., & Bibeau, F. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.08.024 · Cited by 117
Prognostic Value of Perineural Invasion in Colorectal Cancer: A Meta-Analysis
Yang, Y., Huang, X., Sun, J., Gao, P., Song, Y., Chen, X., Zhao, J., & Wang, Z. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2761-z · Cited by 117
Bui, J. D., Uppaluri, R., Hsieh, C., & Schreiber, R. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0556 · Cited by 110
TNM Staging in Colorectal Cancer: T Is for T Cell and M Is for Memory
Broussard, E. K., & Disis, M. L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.9078 · Cited by 100
Metadata
- Authors
- Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., Meatchi, T., Bruneval, P., Cugnenc, P.-H., Trajanoski, Z., Fridman, W.-H., & Galon, J.
- Affiliations
- Inserm (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Graz University of Technology (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-12-22
- Volume
- 353
- Issue
- 25
- Pages
- 2654-2666
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2096151993
- Semantic Scholar
- 608c79dfb95b1632f3cda7f427350880ee435e8a
- Cited by
- 2,135
- References
- 32
- Citations by year
- 2026: 27 · 2025: 57 · 2024: 66 · 2023: 118 · 2022: 117 · 2021: 141 · 2020: 130 · 2019: 123 · 2018: 123 · 2017: 136 · 2016: 135 · 2015: 145 · 2014: 115 · 2013: 135 · 2012: 108
- FWCI
- 27.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- colorectal cancer, effector memory T cells, tumor-infiltrating lymphocytes, CD8+ T cells, CD45RO+ memory T cells, T-cell markers, lymphatic invasion, perineural invasion, interferon-gamma, granzyme B, granulysin, IRF1, disease-free survival, overall survival, antitumor immunity
- MeSH terms
- Analysis of Variance, Embolism, Flow Cytometry, Humans, Lymphatic Metastasis, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Staging, RNA, Messenger, T-Lymphocytes, Colorectal Neoplasms, Gene Expression, Proportional Hazards Models, Survival Analysis, Polymerase Chain Reaction, Lymphocytes, Tumor-Infiltrating, Leukocyte Common Antigens, CD8-Positive T-Lymphocytes, Microarray Analysis, Protein Tyrosine Phosphatase, Non-Receptor Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.